Murphy G J, Kirkham D M, Cawthorne M A, Young P
Diabetes Programme, SmithKline Beecham Pharmaceuticals Research Division, Epsom, Surrey, U.K.
Biochem Pharmacol. 1993 Aug 17;46(4):575-81. doi: 10.1016/0006-2952(93)90540-d.
The lipolytic action of the beta 3-adrenoceptor-selective agonist 4-[2-[(2-hydroxy-2-(3-chlorophenyl)ethyl)-amino]propyl]-phenoxyacetic acid (BRL 37344) was compared to that of isoprenaline in adipocytes derived from rat white adipose tissue. Concentration-response curves for activation of lipolysis by each agonist correlated well with the dose-response curves for activation of cAMP-dependent protein kinase (A-Kinase). Addition of propranolol at a concentration (0.1 microM) sufficient to block beta 1- and beta 2-adrenoceptors did not affect the stimulation of either parameter by BRL 37344 or isoprenaline, indicating that lipolysis was predominantly dependent on beta 3-adrenoceptor stimulation. Blockade of beta 3-adrenoceptors by 3 microM propranolol antagonized both A-Kinase activation and glycerol release. Activation of lipolysis by BRL 37344 was blocked by treatment of the cells with N-[2-p-(bromocinnamylamino)ethyl]-5-isoquinolinesulphonamide (H89) a potent and selective isoquinolinesulphonamide inhibitor of A-Kinase activity. Taken together, these results indicate that lipolysis in rat white adipocytes is primarily controlled by beta 3-adrenoceptors, and that cyclic AMP generation alone is responsible for activation of lipolysis in this tissue.
将β3 - 肾上腺素能受体选择性激动剂4 - [2 - [(2 - 羟基 - 2 - (3 - 氯苯基)乙基)-氨基]丙基]-苯氧基乙酸(BRL 37344)的脂解作用与异丙肾上腺素在源自大鼠白色脂肪组织的脂肪细胞中的脂解作用进行了比较。每种激动剂激活脂解的浓度 - 反应曲线与激活环磷酸腺苷(cAMP)依赖性蛋白激酶(A激酶)的剂量 - 反应曲线密切相关。以足以阻断β1和β2肾上腺素能受体的浓度(0.1微摩尔)添加普萘洛尔,并不影响BRL 37344或异丙肾上腺素对任何一个参数的刺激,这表明脂解主要依赖于β3肾上腺素能受体的刺激。3微摩尔普萘洛尔对β3肾上腺素能受体的阻断作用拮抗了A激酶的激活和甘油释放。用N - [2 - p - (溴肉桂氨基)乙基]-5 - 异喹啉磺酰胺(H89)(一种强效且选择性的异喹啉磺酰胺A激酶活性抑制剂)处理细胞后,BRL 37344激活脂解的作用被阻断。综上所述,这些结果表明大鼠白色脂肪细胞中的脂解主要由β3肾上腺素能受体控制,并且仅环磷酸腺苷的生成就负责该组织中脂解的激活。